ABOUT US
TradeCraft Clinical Research is a life sciences consulting firm providing expertise in the Statistical Programming and Biostatistics disciplines for life sciences organizations. We partner with our clients to provide statistical analysis services for product development, regulatory submissions, and to assist in expediting your therapeutic's approval process.
We've done this before.
Working to produce your deliverables, especially under tight regulations, means that you cannot afford to work with an inexperienced team. Moreover, you want to be sure that you feel comfortable and included each step of the way, while being guided by experts in the field. The TradeCraft team is comprised of programmers with an average of 15 years of experience and Ph.D. level statisticians with an average of 24 years of experience. We have been in the clinical research business for decades. We apply the highest standards based on our longterm CDISC membership - and we having a history of finding what others cannot.
Our proven methodologies and practical solutions are here to help your organization improve data quality, allow you to make data-driven decisions far earlier in your testing process, and then bring your entire team the ability to both understand and articulate the story that your data tells.
How We Work
Our original business model was drafted by examining and (more importantly) addressing the major sticking points between clients and their programming teams as well as critical communication gaps. We looked at how we wanted our industry to function, the necessary steps to create a highly ethical work flow, and how to do so consistently and reliably. We still work this way. You will find your projects to be laid out clearly for you with realistic timelines and a predictable, consistent process enabling us to deliver high-quality, on-time deliverables in support of our clients' goals.
We embrace a startup mentality but offer enterprise experience. Our team includes those with deep domain expertise in the Statistical Programming and Biostatistics disciplines and our process offers powerful, integrated technology solutions that accelerate your organizations journey from data to decision.
Our Corporate Pillars
The TradeCraft model hinges on offering all our clients:
-
Credibility
-
Partnership
-
Communication
-
Technology
LEADERSHIP TEAM
Mike Willis
CEO & Founder
Brittaney Ortland
Vice President,
Project Management
John Ilgenfritz
Vice President, Biostatistics
As our CEO, Mike's focus has always been on keeping us accountable to our clients. His is a process-oriented leadership style that places ethics as our number one priority and follows it up with 22 years of experience in pharmaceuticals, a phenomenal set of technical skills, and a commitment to the exchange of ideas. He is also a PharmaVOICE 100 recipient! Contact
Brittaney is our Vice President of Project Management. Her collaborative approach, attention to detail, and understanding of our clients’ goals help us maintain speed and transparency across our portfolio of projects. Her adept planning methods and flexible management techniques help us deliver greater value to our clients every day.
With going on 30 years of experience in the field, John’s statistical analysis expertise in the planning, analysis, and interpretation of clinical trials is beyond comparison. He knows the industry and focuses on clients’ needs with pinpoint precision.
J. Kanan Sawyer, Ph.D.
Head of Communications
Kanan brings more than two decades of experience in executive communications, marketing, and messaging to our team. She has been a college professor, enterprise keynote writer, author, researcher, and more. (Plus, she keeps correcting our grammar!)
Karl Fischer
VP, Product Development & Software Strategy
With a focus on providing value to clients beyond our core Programming and Biostatistics Services, Karl is guiding our software strategy and leading efforts to develop the DataVIEWS clinical data analysis and visualization tool. We want to leverage the evolving open-source programming technology with CDISC data standards. This approach provides analysis results faster and enables visibility and insights into trial data as early and often as possible to aid decisions and improve the success rate and speed of drug development.